INTRODUCTION
Actinotnycins are chromopeptide antibiotics produced by several different actinomycetes (Waksman, 1968) . The enzymes involved in activation of the precursor of the actinomycin chromophore and in polymerization of the amino acids of the pentapeptide chains have been isolated and characterized (Keller e t al., 1984 ; Keller, 1987 ; Keller & Schlumbohm, 1992; Stindl & Keller, 1993) . In the pathway for actinomycin biosynthesis in Streptomyes antibioticus, phenoxazinone synthase (PHS) may catalyse the penultimate step, namely the oxidative condensation of two molecules of 4-methyl 3-hydroxyanthraniloyl pentapeptide lactone to generate actinomycinic acid (Katz & Weissbach, 1962) . The structural gene for PHS (phsA) has been cloned in S. lividans, an organism that does not normally produce either PHS or actinomycin D (Jones & Hopwood, 1984a) . Another cloned sequence, 4.3 kb in size and also derived from S. antibioticus, was shown to activate an otherwise silent phs gene in S. lividans (Jones & The GenBank accession number for the sequence (719 bp insert from pJSM550) reported in this paper is L14560. Hopwood, 1984b) . The silent gene has been cloned in Escherichia coli (Madu & Jones, 1989 ).
Cryptic genes have been defined as phenotypically silent DNA sequences that are not normally expressed during the life cycle of an organism but which can be activated as a result of rare genetic events such as point mutations, transposition of a mobile genetic element or recombination (Hall e t al., 1983) . These cryptic genes are retained through cycles of decryptification and cryptification in response to environmental changes (Hall e t al., 1983) . Silent genes, on the other hand, have been defined as unexpressed genes originating from duplications that do not confer a phenotype, and which are therefore not subject to selection pressure (Beacham, 1987) . The phs gene from 5'. lividans will be referred to as silent since no PHS activity has been detected except upon the introduction of the S. antibioticus 4.3 kb sequence.
Several mechanisms by which the 4.3 kb sequence could activate the phs gene of S. lividans can be envisaged. The sequence could code for a protein or RNA activator that acts at the transcriptional or translational level, or even at the post-translational level (for example by modifying an inactive PHS precursor). Alternatively, the 4.3 kb sequence could act as an operator capable of titrating a repressor in the mycelium, resulting in the derepression of phs. 
To characterize further the 4.3 kb sequence and distinguish between these possibilities, we used a subcloning analysis followed by DNA sequencing, dot-blot assays of' total RNA and the use of an in vitro coupled transcriptiontranslation system. Our results indicate that no protein or KNA gene product is needed to activate the silent gene in S. lividans. Furthermore, the activating sequence has been. localized to a 249 bp fragment with a region of strong dyad symmetry; disruption of this region destroys tht: activation phenotype.
METHODS
Organisms, growth conditions and plasmids. The S. lividams 66 derivative TIC24 (Hopwood e t al., 1983) was cultured and used to prepare protoplasts and transformed as described previously (Hopwood e t al., 1985; Jones & Hopwood, 1984a,, b) . The PHS assay was done with mycelium grown oi galactose-glutamic acid (GGA) agar (Gallo & Katz, 1972 Bullock etal., 1987) and M147 (dam dcmgalara lm tbr leu tbi tonA tsx rpsL supE), obtained from Brian Spratt, University of Sussex, UK, were cultured in L broth and L agar.
DNA isolation and manipulation. Plasmid and chromosomal D N As were prepared and manipulated as described in earlier publications (Hopwood e t al., 1985; Jones & Hopwood, 1984a, PCR cloning. Primers for the polymerase chain reaction were obtained from the DNA Synthesis Core at the Biomedical Research Core Facilities of the University of Michigan. The sequences of primers pB1 and pB2 were 5'GAGGCATGCT'I'-CGTGACGATCATGAA3' and 5'GAGTGATCATGAACC-CGCTTGCTGAT3', respectively. The underlined bases represent an JpbI site in the case of pBl and a BclZ site in the case of pB2. PCR was done as described in Gould e t al. (1989) using 1 pg of each of the primers, and 200 ng in the case of plasn-id DNA or 1 pg of genomic template DNA. pJSM550 (Table 1) was used as the template for the synthesis of the S. antibiotzcw sequence spanning the two BamHI sites of the 719 bp BclZ-Si)bI fragment of PI 52502 ( Fig. 1 b, RNA isolation and dot-blot analysis. RNA was isolated from 48 h liquid cultures grown either in yeast extract/malt extract (YEME) medium supplemented with sucrose or in GGA medium as described in Hopwood e t al. (1985) except that the b) * high salt precipitation step was omitted. Thus the RNA preparations would be expected to contain both high and low molecular mass RNAs. Increasing amounts of RNA were then spotted on a Nytran membrane using a filtration manifold (Bio- 
,250 bp, Rad). Filters were prehybridized overnight and hybridized for 40 h a t 68 OC with 32P-labelled probes as described previously (Jones & Hopwood, 1984a, b) .
In vitro coupled transcription-translation. Reaction mixtures for coupled transcription-translation typically contained 2.25 pg of template DNA, the other components indicated by Thompson et ul. (1984) and [35S] methionine. Samples were analysed by denaturing polyacrylamide gel electrophoresis and fluorography exactly as described by Jones & Hopwood (1984a) .
Miscellaneous methods. PHS was assayed as described previously (Choy & Jones, 1981; Jones & Hopwood, 1984a) . Protein was determined as described by Bradford (1976) . The copy number of pJSM620 was estimated by fractionation of total DNA from 5'. lividans transformants on CsCl (Hopwood e t al., l985), using a value of 10000 kb as the size of the S. lividans genome (Goodfellow & Cross, 1983) .
RESULTS

Identification of a region of the 4.3 kb insert retaining the ability to activate PHS expression
The sequence responsible for activating PHS expression in S. lzvidans was localized to a specific region of the 4.3 k b fragment cloned in pIJ2502 from S. antibioticas. Advantage was taken of several restriction sites in pIJ2502 that furnished fragments that could b e cloned in the BgAI site of pIJ702. These experiments ( Fig. 1 and Table 2) identified a 985 bp BclI fragment that retained the ability t o activate phs (the insert of pJSM520, Fig. la) . T h e fragment, which contained 266 bp from pIJ702 and 719 bp f r o m the 4.3 k b insert of pIJ2502 (Jones & G C C A C GCCACCGGCG GGGCGCACCC:  70  80  90  100  CCACCGGAAG GGACGTCCGC TCGGAAAGGA ATTGCCCCTT  120  130  140  lSCl  GCGAGGACCG CCGCGAGCAA GACCATCTTT GTTCAACATT  170  180  190  200  CATTAATTGT CCGGATCGCG GCCAACCGGT CCGGGCCGAT  220  Orfl-240  250  CTCCTCCGGT CGATAGGTUCGGGGTCG'RXACCCAACC;  SphI  Orf2 -280  2 90  300  GGTCCC-GCCTCCCC  TCCCCCCGGC CGCGCACGCT  320  330  340  350  CTCTTCGGGA TGCAGGCGGT GCTGATAGCG ATCGTCGTCG  370  380  390  40C  GCTGTTCGCC TGGGCCAGCA ACCACCGCCA GGCCGAGGAC  420  430  440 (Fig. 4) is shown in bold and the sequences of the primers used for the PCR are italicized.
control. Extracts of mycelium transformed with either the high or low copy number derivatives gave similar levels of PHS activity (Table 2) . Moreover, the observed values were comparable to the PHS specific activity in pIJ2502 transformants. We estimate the copy number of p J SM620 to be five to eight copies per chromosome.
Sequence analysis
Both strands of the 985 bp BcA fragment described above were sequenced on the average three to four times. The sequence of the vector-derived portion was as reported by Bernan e t al. (1985) . The sequence of the entire fragment is shown in Fig. 2 (Fig. lb) . As shown in Table 3 , the G + C distribution in ORFs 1-5 is unlike that normally observed in streptomycete genes (Bibb et al., 1984) . Finally, no similarity of the predicted products of ORFs 1-5 to any protein in GenBank was discerned. Hopwood, 1984b) , was cloned into the BgAI site of pIJ702 in the same orientation as in pIJ2502 (Fig. la) . When this fragment was further subcloned to yield recombinant plasmids p J SM521, p J SM522 and p J SM52?8 (Fig. lb) , the activation phenotype was lost.
Effect of copy number on the activation of PHS
To study the dosage effect on the activation of the S. lividansphs gene, the 985 bp BclI fragment cloned from pIJ2502 in pJSM520 was subcloned into the low copy number plasmid pIJ922 to give pJSM620. pIJ922 is present at three to five copies per genome (Lydiate e t al., 1985) . S. lividans strains harbouring the vectors pIJ702 or PI J922 were used as negative controls. Transformants carrying the recombinant plasmid PI J2501 (the PI 5702 derivative bearing the phs structural gene from S. antibiotzcus; Jones & Hopwood, 1984a) were used as a positive
S. liwidans transformants do not contain messenger or structural RNAs related to the 719 bp fragment
Total RNA was isolated from 5'. lividans mycelium transformed with pJSM520 or pIJ2501 (see Table 1 ).
Cultures were grown for 48 h in YEME medium or, in some cases, in actinomycin production (GGA) medium. RNA from the pJSM520 derivative was probed with both PI 5702 and p JSM550; RNA from the PI 52501 derivative was probed with PI 52505. PI 5550 consisted of the active BcLI-SphI fragment in pBluescript ICS + (Table 1 ). pIJ702 and pIJ2505 were used as positive controls; the former should detect the mRNA for the thiostrepton resistance gene (Thompson e t al., 1982) as well as other messenger RNAs encoded by the plasmid (Kendall & Cohen, l988), and the latter should detect phs mRNA. Increasing amounts, up to 50 pg of RNA from mycelium cultured on YEME or GGA, were spotted on a Nytran membrane. The appropriate DNA positive control was included in each case. As shown in Fig. 3(b) , no signal was observed (Fig. 3a) or pIJ2505 (Fig. 3c) . The filters shown in Fig. 3 were overexposed to facilitate identification of any hybrids that might have been formed with pJSM550 as the probe (Fig. 3b) . This probably accounts for the apparent failure of the signal strength to vary linearly with RNA concentration in Fig. 3(a, c) . Exposure of the filters for even longer periods did not modify the results shown in Fig. 3 .
To compare results from this experiment to a negative control, pBluescript KS+ was used to probe the same amounts of RNA from S. lividans transformed with pJSM520 (data not shown). The appropriate DNA positive controls were also spotted on the filters. The two filters, probed with pBluescript KS + and with pJSM550, showed similar results after exposure for 3 d (data not shown). Exposure of the filters for 7 d still did not reveal RNAs that hybridized specifically to the p JSM550 insert. The results of these experiments have other implications. Since total RNA was probed with the insert of interest, RNA products such as rRNA and tRNA should have been detected. They were not. Similar results were obtained in control experiments like those just described but using the insert of pIJ2502 as the probe (data not shown). Moreover, no similarity to any known RNA was revealed when the 719 bp sequence was used to search GenBank.
Finally, in other experiments (not shown), using the streptomycete coupled transcription-translation system, the insert of pJSM520 did not encode polypeptides of sizes that corresponded to those of the putative ORFs described in the preceding section. Therefore, neither RNA nor protein products of the BclI-SphI fragment appear to be involved in the activation ofphs in S. lividans.
It should be noted here that Southern Cross hybridization experiments (Potter & Dressler, 1986) ruled out the possibility of rearrangement of the activating fragment or the region of the S. lividans genome corresponding to the activating fragment (Madu & Jones, 1989) in transformants containing PI 52502 (unpublished results).
S. antibioticus
S. lividans
Only a 249 bp fragment derived from the Bcll sequence is necessary for the activation phenotype
The results presented above suggested that the activating sequence overlapped one or both BamHI sites of PI 52502 (Fig. la) . Since no convenient restriction sites for subcloning were available outside the two BamHI sites, two primers were synthesized, each 26 bases long and containing 17 bases complementary to the sequence of interest (Fig. 2) . The remaining bases were an SphI site plus three randomly chosen bases for pB1, and a BcA site plus three other random bases for pB2 (see Methods). The two primers were used along with the DNA template pJSM550 in a PCR reaction. The amplified region spanning the two BamHI sites was in turn cloned into pIJ702 to yield pJSM524. The relationship between the PCR fragment and the various subclones of pIJ2502 is shown in Fig. l(c) . Clones containing the PCR fragment were assayed for PHS activity. Results from this experiment indicated that the working hypothesis was correct and that this 249 bp fragment was able to activate phs expression in S. lividans (Table 2 ).
The sequence of the PCR product was determined for four independent clones and compared with the sequence of the 719 bp activator fragment. The cloned PCR fragment overlaps the rightmost (as depicted in Fig. 1 ) BamHI site of pJSM524. If the region around that site is required for the function of the activating fragment, the loss of the activation phenotype ( Fig. 1 b) upon cloning of the BamHI fragment into the BgAI site of PI 5702 would be explained. No sequence similar to the 249 bp fragment was detected in GenBank.
PCR cloning of a fragment from 5. lividans with homology to the S. antibioticus activator fragment
The two primers utilized in the previous experiment were used in a PCR reaction with S. lividans genomic DNA as the template. Annealing was done at 55 "C and 65 OC; the second reaction gave a product with a mobility similar to the S. antibioticus product on a 1.6 % agarose gel. The PCR product was in turn digested with SphI and BclI and cloned in E . coli M147 in the modified KS+ and SIC+ Bluescript vectors. The sequences of five different clones were determined and compared to the S. antibioticus sequence (Fig. 4) . The two sequences were 95 % identical and contained a region around one of the BamHI sites that exhibited dyad symmetry. This sequence, which starts at lividans PCR products. The two sequences are identical in both organisms except for a single bp change (bold). Two bases from one of the inverted repeats (italics) were lost when the BarnHl fragment of plJ2502 was cloned to generate pJSM522.
Complementary bases are underlined. plJ522 (Fig. 1) does not activate phs.
nucleotide 713 and ends at nucleotide 744 ( Fig. 2) , might generate a stable hairpin structure that could function as a protein recognition sequence. One of the differences between the S. lividans and S. antibioticus sequences occurs in the region of dyad symmetry; this renders the 5'. lividans structure potentially less stable because of one fewer GC bond in the stem region (Fig. 5) .
The 243 bp PCR product from S. lividans was cloned between the BgAI and SphI sites of pIJ702 giving pJSM525. The recombinant plasmid was used to transform 5'. lividans protoplasts. The PHS specific activity in these transformants was lower than that observed in transformants containing the S. antibioticus PCR product and was also lower than the activities observed in transformants containing PI 52502, p JSM520 or p JSM620. However, PHS activities were easily measured in transformants containing the PCR products and replicate assay results varied by no more than 4 %. The reasons for the decreased levels of PHS in transformants containing the PCR products is not known at present.
DISCUSSION
Interest in the activation of the silent phs gene from S. lividans emerges from several interesting observations. First, PHS activity was detected in a number of streptomycetes, producers as well as non-producers of actinomycin D, upon transformation with the recombinant plasmid pIJ2502 (Jones & Hopwood, 1984b) . Second, it was shown by both cloning (Madu & Jones, 1989) and Southern hybridizations that sequences similar to the PHS structural gene and the 4.3 kb activator fragment exist in the genomes of these organisms. These findings raised the exciting possibility that silent genes or even pathways for antibiotic production are present in members of this group. Streptomycetes possess a large genome, of the order of 8000-10000 kb (Goodfellow & Cross, 1983 ; Kieser et al., 1992 ; Leblond et al., 1993) . Perhaps a significant fraction of these genomes harbour silent While the mechanism of activation of the silentphs gene in
5'. lividans appears thus far to be novel in the genus
Strrptomyces, similar systems are present in enteric bacteria. Thus, the eel operon of E. coli K12, which is involved in the utilization of p-glucoside sugars, consists of five genes, celABCDF, and is cryptic because it is in a constant state of repression (Parker & Hall, 1990a, b) . The product of celD is a negative regulatory protein that prevents expression of the wild-type eel operon. Activation of this operon results from point mutations in celD, or from insertions in an upstream regulatory sequence, presumably the sequence normally recognized by the repressor product of celD. The putative presence of such a system in 5'. liziidans may indicate that the phenomenon of cryptic and silent genes is as widespread among streptomycetes as in other micro-organisms.
